Drug Shortage Report for APO-CANDESARTAN
Report ID | 166595 |
Drug Identification Number | 02365367 |
Brand name | APO-CANDESARTAN |
Common or Proper name | CANDESARTAN |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | CANDESARTAN CILEXETIL |
Strength(s) | 16MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL and 30 BLS |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-08-09 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-08-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-08-12 | French | Compare |
v1 | 2022-08-12 | English | Compare |
Showing 1 to 2 of 2